Search Page

1

Cite

Share

Workshop of European task force on medication-related osteonecrosis of the jaw-Current challenges.

Schiodt M, Otto S, Fedele S, Bedogni A, Nicolatou-Galitis O, Guggenberger R, Herlofson BB, Ristow O, Kofod T. Schiodt M, et al. Oral Dis. 2019 Oct;25(7):1815-1821. doi: 10.1111/odi.13160. Epub 2019 Aug 19. Oral Dis. 2019. PMID: 31325201 Free article. No abstract available.

Cite

Share

2

Cite

Share

Treatment of osteonecrosis of the jaw related to bisphosphonates and other antiresorptive agents.

Rodriguez-Lozano FJ, Oñate-Sánchez RE. Rodriguez-Lozano FJ, et al. Med Oral Patol Oral Cir Bucal. 2016 Sep 1;21(5):e595-600. doi: 10.4317/medoral.20980. Med Oral Patol Oral Cir Bucal. 2016. PMID: 27475683 Free PMC article. Review.

Cite

Share

3

Cite

Share

Treatment strategies and outcomes of bisphosphonate-related osteonecrosis of the jaw (BRONJ) with characterization of patients: a systematic review.

Fliefel R, Tröltzsch M, Kühnisch J, Ehrenfeld M, Otto S. Fliefel R, et al. Int J Oral Maxillofac Surg. 2015 May;44(5):568-85. doi: 10.1016/j.ijom.2015.01.026. Epub 2015 Feb 26. Int J Oral Maxillofac Surg. 2015. PMID: 25726090 Review.

Cite

Share

4

Cite

Share

Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review.

Nicolatou-Galitis O, Kouri M, Papadopoulou E, Vardas E, Galiti D, Epstein JB, Elad S, Campisi G, Tsoukalas N, Bektas-Kayhan K, Tan W, Body JJ, Migliorati C, Lalla RV; MASCC Bone Study Group. Nicolatou-Galitis O, et al. Support Care Cancer. 2019 Feb;27(2):383-394. doi: 10.1007/s00520-018-4501-x. Epub 2018 Oct 23. Support Care Cancer. 2019. PMID: 30353228

Cite

Share

5

Cite

Share

Concentration of Penicillin G in Jawbone Affected by Antiresorptive Agent-Related Osteonecrosis Following a Single Preoperative Dose.

Poxleitner P, Ermer MA, Trittler R, Feuerstein CL, Otten JE, Schmelzeisen R, Voss PJ, Steybe D. Poxleitner P, et al. Antibiotics (Basel). 2020 Dec 27;10(1):17. doi: 10.3390/antibiotics10010017. Antibiotics (Basel). 2020. PMID: 33375399 Free PMC article.

Cite

Share

6

Cite

Share

Osteonecrosis of the jaw - prevention and treatment strategies for oral health professionals.

Hinchy NV, Jayaprakash V, Rossitto RA, Anders PL, Korff KC, Canallatos P, Sullivan MA. Hinchy NV, et al. Oral Oncol. 2013 Sep;49(9):878-886. doi: 10.1016/j.oraloncology.2013.06.008. Epub 2013 Jul 23. Oral Oncol. 2013. PMID: 23890929 Review.

Cite

Share

7

Cite

Share

^☆Symposium: Imaging modalities for drug-related osteonecrosis of the jaw (5), utility of bone scintigraphy and ¹⁸F-FDG PET/CT in early detection and risk assessment of medication-related osteonecrosis of the jaw (secondary publication).

Watanabe S, Nakajima K, Kinuya S. Watanabe S, et al. Jpn Dent Sci Rev. 2019 Nov;55(1):76-79. doi: 10.1016/j.jdsr.2018.12.002. Epub 2019 Mar 20. Jpn Dent Sci Rev. 2019. PMID: 30956739 Free PMC article. Review.

Cite

Share

8

Cite

Share

Bisphosphonate-related osteonecrosis of the jaws. A severe side effect of bisphosphonate therapy.

Janovská Z. Janovská Z. Acta Medica (Hradec Kralove). 2012;55(3):111-5. doi: 10.14712/18059694.2015.47. Acta Medica (Hradec Kralove). 2012. PMID: 23297518 Free article. Review.

Cite

Share

9

Cite

Share

Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS.

Anastasilakis AD, Pepe J, Napoli N, Palermo A, Magopoulos C, Khan AA, Zillikens MC, Body JJ. Anastasilakis AD, et al. J Clin Endocrinol Metab. 2022 Apr 19;107(5):1441-1460. doi: 10.1210/clinem/dgab888. J Clin Endocrinol Metab. 2022. PMID: 34922381 Free PMC article. Review.

Cite

Share

10

Cite

Share

¹⁸F-Fluoride PET/CT Imaging of Medication-Related Osteonecrosis of the Jaw in Conservative Treatment-A Case Report.

Reinert CP, Pfannenberg C, Gatidis S, la Fougère C, Nikolaou K, Hoefert S. Reinert CP, et al. Front Oncol. 2021 Jul 1;11:700397. doi: 10.3389/fonc.2021.700397. eCollection 2021. Front Oncol. 2021. PMID: 34277447 Free PMC article.

Cite

Share